Si Bone, Inc. SIBN
We take great care to ensure that the data presented and summarized in this overview for SI-BONE, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SIBN
View all-
Brown Advisory Inc4.22MShares$52.8 Million0.09% of portfolio
-
Black Rock Inc. New York, NY3.92MShares$49 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.17MShares$39.7 Million1.17% of portfolio
-
First Light Asset Management, LLC Edina, MN2.47MShares$30.9 Million3.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$30.8 Million0.0% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.45MShares$30.7 Million0.24% of portfolio
-
American Century Companies Inc Kansas City, MO1.62MShares$20.2 Million0.02% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.59MShares$19.9 Million0.94% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.14MShares$14.2 Million0.29% of portfolio
-
Paradigm Capital Management Inc1.08MShares$13.5 Million0.86% of portfolio
Latest Institutional Activity in SIBN
Top Purchases
Top Sells
About SIBN
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Insider Transactions at SIBN
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 14
2024
|
Laura Francis Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,669
+6.2%
|
$274,676
$4.5 P/Share
|
Jun 10
2024
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
341
-1.78%
|
$4,092
$12.99 P/Share
|
May 17
2024
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
2,068
-0.83%
|
$28,952
$14.84 P/Share
|
May 16
2024
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
1,581
-6.85%
|
$23,715
$15.13 P/Share
|
May 16
2024
|
Anshul Maheshwari Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,441
-0.59%
|
$36,615
$15.14 P/Share
|
May 16
2024
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
3,941
-0.52%
|
$59,115
$15.11 P/Share
|
May 02
2024
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
343
-1.43%
|
$4,802
$14.54 P/Share
|
Apr 03
2024
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
920
-0.36%
|
$13,800
$15.63 P/Share
|
Apr 02
2024
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
3,307
-0.65%
|
$49,605
$15.51 P/Share
|
Apr 02
2024
|
Anshul Maheshwari Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,425
-0.58%
|
$36,375
$15.46 P/Share
|
Mar 13
2024
|
Mika Nishimura |
SELL
Open market or private sale
|
Direct |
2,500
-11.44%
|
$40,000
$16.22 P/Share
|
Mar 13
2024
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
3,330
-1.29%
|
$53,280
$16.82 P/Share
|
Feb 16
2024
|
Anshul Maheshwari Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,336
-0.86%
|
$146,720
$20.95 P/Share
|
Feb 16
2024
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
7,822
-0.59%
|
$156,440
$20.95 P/Share
|
Feb 16
2024
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
4,160
-3.23%
|
$83,200
$20.95 P/Share
|
Feb 16
2024
|
Laura Francis Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
38,587
-1.05%
|
$771,740
$20.95 P/Share
|
Feb 02
2024
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
335
-0.75%
|
$6,700
$20.3 P/Share
|
Jan 05
2024
|
Laura Francis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
201,306
+17.17%
|
-
|
Jan 05
2024
|
Anshul Maheshwari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
68,009
+13.89%
|
-
|
Jan 05
2024
|
Anthony J Recupero President, Commercial Ops |
BUY
Grant, award, or other acquisition
|
Direct |
68,009
+11.47%
|
-
|
Last 12 Months Summary
Exercise of conversion of derivative security | 150K shares |
---|---|
Grant, award, or other acquisition | 337K shares |
Open market or private sale | 239K shares |
---|